Innovating Works

H2020

Cerrada
HORIZON-INFRA-2021-DEV-02-01
Preparatory phase of new ESFRI research infrastructure projects
ExpectedOutcome:Project results are expected to contribute to several of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 101 al 120 de 230 resultados
DUCA: Data Usage Control for empowering digital sovereignty for All citizens SOUTH EAST TECHNOLOGICAL UNIVERSITY tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Driven by the growing concern on the usage of personal and sensitive data in the Internet, DUCA aims at providing a framework to empower Eur...
2023-01-01 - 2026-12-31 | Financiado
HEPINIB: Heparanase inhibition as a multifunctional targeting approach in cancer UNIVERSITAET MUENSTER tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Cancer is a leading cause of mortality within the aging European population. Therapeutic targeting is hampered by the complexity of the dise...
2023-01-01 - 2026-12-31 | Financiado
Bio-Acouis: Bio-based Solutions for Improved Acoustic Applications TOSUNOGULLARI MOBILYA SANAYI VE TICARET ANONIM SIRKETI tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 The project focuses on a highly actual problem of the society and economy, noise is one of the major issue for people who spent most of her...
2023-01-01 - 2026-12-31 | Financiado
ReCharged: Climate-aware Resilience for Sustainable Critical and interdependent Infrastructure Systems enhanced... GRID ENGINEERS IKE tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 ReCharged is a transformative project that has the vision to develop a new integrated framework toward a practical visualisation platform in...
2023-01-01 - 2026-12-31 | Financiado
CaLIGOLA: Cartan geometry, Lie and representation theory, Integrable Systems, quantum Groups and quantum compu... ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 CaLIGOLA aims at advancing the research in Cartan Geometry, Lie Theory, Integrable Systems and Quantum Groups to provide insight into a vari...
2023-01-01 - 2026-12-31 | Financiado
Nano-ImmunoEra: NANOTECHNOLOGY-ENABLED DETECTION OF CLINICALLY RELEVANT ANTIBODIES FOR EARLY CANCER DIAGNOSIS AND IM... ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Nano-ImmunoEra is a research and innovation staff exchange network aiming at the development of innovative biosensors and diagnostic tools f...
2023-01-01 - 2026-12-31 | Financiado
REMARKABLE: Rural Environmental Monitoring via ultra wide-ARea networKs And distriButed federated Learning PDM E FC PROJECTO DESENVOLVIMENTO MANUTENCAO FORMACAO E CONSULTADORIALDA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Internet of Things (IoT) technology combined with complementary support for data analytics is the corner stone of today's digital transforma...
2023-01-01 - 2026-12-31 | Financiado
Invest4Health: Mobilising novel finance models for health promotion and disease prevention REGION SKANE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-02 In the medium to longer-term, the fiscal space that governments have to provide additional budgetary resources will shrink, including for he...
2023-01-01 - 2026-06-30 | Financiado
CARE-IN-HEALTH: CArdiovascularREsolution of INflammation to promote HEALTH INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 With 1.9 million deaths and an economic burden estimated to €200 billion each year in Europe, cardiovascular diseases (CVD) represent a sign...
2023-01-01 - 2027-12-31 | Financiado
INITIALISE: Inflammation in human early life: targeting impacts on life-course health TURUN YLIOPISTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The development of the human immune system in early life, including in utero, impacts the risks of several diseases later in life, particula...
2023-01-01 - 2028-12-31 | Financiado
miGut-Health: Personalised blueprint intestinal health UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease....
2023-01-01 - 2026-12-31 | Financiado
Hypermarker: Personalised pharmacometabolomic optimisation of treatment for hypertension UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Hypertension, or high blood pressure (BP), is a serious medical condition, and the single biggest contributor to circulatory diseases which...
2023-01-01 - 2026-12-31 | Financiado
Real4Reg: Development, optimisation and implementation of artificial intelligence methods for real world data... BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Real-world evidence derived from real-world data (RWD) has a promising role to inform regulatory decision-making. Based on highly relevant u...
2023-01-01 - 2026-12-31 | Financiado
PRAESIIDIUM: PHYSICS INFORMED MACHINE LEARNING-BASED PREDICTION AND REVERSION OF IMPAIRED FASTING GLUCOSE MANAGEM... SPINDOX LABS SRL tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The incidence of undiagnosed diabetes accounts for 36% European adults, while 541M adults worldwide have Impaired Glucose Tolerance (IGT), a...
2023-01-01 - 2025-12-31 | Financiado
PRIME-CKD: Personalized Drug Response: IMplementation and Evaluation in CKD ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Chronic Kidney Disease (CKD) is one of the major causes of death in high income countries and its prevalence is growing rapidly. New therapi...
2023-01-01 - 2027-12-31 | Financiado
FLASH: Flexible Approaches to Support Health through financing UNIVERSITA DEGLI STUDI DI VERONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-02 One of the lessons learnt from the Covid-19 pandemic is the importance of flexibility in funding and organization of health systems. Europea...
2023-01-01 - 2026-12-31 | Financiado
REDDIE: Real-world evidence for decisions in diabetes MEDIZINISCHE UNIVERSITAT GRAZ tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Randomised controlled trials are the cornerstone of evidence-based medicine. However, the digitisation of real-world data (RWD) including da...
2023-01-01 - 2026-12-31 | Financiado
GlycanTrigger: GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 Chronic inflammation underlies several diseases. In Crohn´s disease (CD), there is mounting evidence of a preclinical phase characterized by...
2023-01-01 - 2028-12-31 | Financiado
INTERCEPT-T2D: Early Interception of Inflammatory-mediated Type 2 Diabetes INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The overall concept of INTERCEPT-T2D is to establish whether an inflammatory-mediated profile contributes to the onset of Type 2 Diabetes (T...
2023-01-01 - 2027-12-31 | Financiado
BEST-COST: Burden of disease based methods for estimating the socio-economic cost of environmental stressors SCIENSANO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-ENVHLTH-04-01 The outdoor environment has a significant impact on our health and wellbeing. The European Green Deal has introduced the ambitious commitmen...
2023-01-01 - 2026-12-31 | Financiado